Nocturnal asthma: underlying mechanisms and treatment.

Ainda não traduzido Ainda não traduzido
Autores
Categoria Primary study
RevistaCurrent allergy and asthma reports
Year 2005

This article is not included in any systematic review

Loading references information
Nocturnal asthma is defined by a drop in forced expiratory volume in 1 second (FEV(1)) of at least 15% between bedtime and awakening in patients with clinical and physiologic evidence of asthma. Nocturnal symptoms are a common part of the asthma clinical syndrome; up to 75% of asthmatics are awakened by asthma symptoms at least once per week, and approximately 40% experience nocturnal symptoms on a nightly basis. An extensive body of research has demonstrated that nocturnal symptoms such as cough and dyspnea are accompanied by increases in airflow limitation, airway hyperresponsiveness, and airway inflammation. Treatment strategies in nocturnal asthma are similar to those used in persistent asthma, although dosing of medications to target optimum delivery during periods of nocturnal worsening is beneficial.
Epistemonikos ID: a187a7220a577e4f8dc40e9f3e0822b425fc525b
First added on: Aug 31, 2024